Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease
Lunawati L Bennett, Kelsey TurcotteSchool of Pharmacy, Union University, Jackson, TN, USA Abstract: The purpose of this article is to review eliglustat tartrate, a substrate reduction therapy, for the treatment of Gaucher disease type 1 (GD1).GD is an rare inborn error of metabolism caused by accumulation of lipid substrates such Hats as glucosylce